# US 2006/0154257 A1 · Screening method for identification of efficient pre-trans-splicing molecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154257 A1
- Document ID: US20060154257A1
- Status: Published application
- Kind: A1
- Application number: 10/898,748
- Filed: 2004-07-26
- Published: 2006-07-13
- Earliest claimed: 2002-10-23
- Inventors: Lloyd Mitchell; Madaiah Puttaraju; Mariano Garcia-Blanco; Edward Otto; Yanping Yang
- Web page: https://patentgrep.com/patent/US20060154257A1

## CPC

- C12N 15/1027: {by DNA shuffling, e.g. RSR, STEP, RPR}
- C12N 15/1086: {Preparation or screening of expression libraries, e.g. reporter assays}
- G01N 33/5023: {on expression patterns}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides methods and compositions for rapid high capacity functional screening to identify optimal pre-trans-splicing molecules (PTMs). The compositions of the invention include PTM expression libraries capable of encoding candidate PTMs designed to interact with a target precursor messenger RNA molecule (target pre-mRNA) and mediate a trans-splicing reaction resulting in the generation of a novel chimeric RNA molecule (chimeric RNA). The candidate PTMs of the invention encode a portion of a first reporter molecule and may encode one or more other reporter molecules, which can be used to select for cells expressing optimal PTMs (efficient and specific). The compositions of the invention also include cells that express a target pre-mRNA encoding the remaining portion of the first reporter molecule. The screening methods of the invention encompass (i) contacting a PTM expression library with cells expressing a target pre-mRNA under conditions in which a trans-splicing reaction will occur in the presence of an optimal PTM (expressed by the library vector) resulting in the formation of a chimeric repaired RNA molecule capable of encoding at least one reporter molecule; (ii) selecting for cells expressing the repaired reporter molecule wherein expression of the reporter molecule indicates the presence of an optimal PTM in the selected cell; and (iii) identifying the optimal PTM expressed in the selected cell(s). The additional reporter molecule(s) can be used to assess both specific and non-specific trans-splicing, as well direct PTM expression.

## Claims

### Claim 1

A method for identifying a PTM capable of mediating at trans-splicing reaction comprising:
(i) contacting a PTM expression library with cells expressing a target pre-mRNA under conditions in which a trans-splicing reaction will occur in the presence of one or more PTMs capable of mediating at trans-splicing reaction wherein said PTM comprises a (i) target binding domain; (ii) a 3′ splice region and/or a 5′ splice region; and (iii) at least one nucleic acid sequence capable of encoding a portion of, or an entire coding sequence of a reporter molecule and wherein a trans-splicing reaction results in the formation of a chimeric RNA molecule capable of encoding a complete reporter molecule;
(ii) selecting for cells expressing the reporter molecule wherein expression of the reporter molecule indicates the presence of a PTM capable of mediating a trans-splicing reaction in the selected cell; and
(iii) identifying the PTM expressed in the selected cell(s).

### Claim 2 (depends on 1)

The method of claim 1 wherein said PTM further comprises a spacer region that separates the splice region from the target binding domain.

### Claim 3 (depends on 1)

The method of claim 1 wherein said PTM further comprises a safety sequence.

### Claim 4 (depends on 1)

The method of claim 1 wherein said PTM further comprises an internal ribosome entry site.

### Claim 5 (depends on 1)

The method of claim 1 wherein the reporter molecule is selected from the group consisting of: (i) a bioluminescent molecule (ii) a fluorescent molecule; (iii) a receptor molecule; (iv) an enzyme molecule; or (v) a protein/peptide tag.

### Claim 6 (depends on 4)

The method of claim 4 wherein the PTM molecule further comprises a second nucleic acid molecule capable of encoding a full length reporter molecule.

### Claim 7 (depends on 1)

The method of claim 1 wherein the cell expressing the target pre-mRNA is genetically engineered to express the target pre-mRNA.

### Claim 8 (depends on 1)

The method of claim 1 wherein said PTM molecule comprises randomized nucleic acid sequences.

### Claim 9 (depends on 1)

The method of claim 1 wherein said PTM comprises nucleic acid sequences that are complementary to the target pre-mRNA.

### Claim 10

A PTM expression library capable of encoding candidate PTMs capable of mediating at trans-splicing reaction wherein said candidate PTMs comprises (i) a target binding domain; (ii) a 3′ splice region and/or a 5′ splice region; and (iii) at least one nucleic acid sequence capable of encoding a portion of, or an entire coding sequence of a reporter molecule.

### Claim 11 (depends on 10)

The method of claim 10 wherein said PTM further comprises a spacer region that separates the splice region from the target binding domain.

### Claim 12 (depends on 10)

The method of claim 10 wherein said PTM further comprises a safety sequence.

### Claim 13 (depends on 10)

The method of claim 10 wherein said PTM further comprises an internal ribosome entry site.

### Claim 14 (depends on 10)

The method of claim 10 wherein the reporter molecule is selected from the group consisting of; (i) a bioluminescent molecule (ii) a fluorescent molecule; (iii) a receptor molecule; (iv) an enzyme molecule; or (v) a protein/peptide tag.

### Claim 15 (depends on 10)

The method of claim 10 wherein the PTM molecule further comprises a second nucleic acid molecule encoding a full length reporter molecule.

### Claim 16 (depends on 10)

The method of claim 10 wherein the cell expressing the target pre-mRNA is genetically engineered to express the target pre-mRNA.

### Claim 17 (depends on 10)

The method of claim 10 wherein said PTM molecules comprise random nucleic acid sequences.

### Claim 18 (depends on 10)

The method of claim 10 wherein said PTM comprises nucleic acid sequences that are complementary to the target pre-mRNA.

### Claim 19

A culture of mammalian cells wherein said cells contain members of the PTM expression library.

### Claim 20 (depends on 1)

The method of claim 1 wherein cells expressing optimal PTMs are selected for by fluorescent cell sorting.
